News Myeloma drugs Darzalex and Kyprolis rejected in Scotland SMC says "no" to Amgen and Janssen multiple myeloma drugs.
News Janssen drug approved in combination against myeloma FDA backs Darzalex in multiple myeloma second line.
News NICE rejects Amgen's Kyprolis in multiple myeloma NICE rejects drug despite efficacy and quality of life evidence.
News New Breakthrough status for Darzalex in earlier myeloma trea... Janssen's drug looking to gain bigger share in crowded myeloma market
News Janssen's Darzalex approved for myeloma in Europe Darzalex, a first-in-class treatment for multiple myeloma has been approved in Europe, adding to an increasingly competitive disease area.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
